NCODA Logo

toolkit resources

NCODA’s Toolkit Resources, are peer-reviewed essential tools and guidelines designed specifically for oncology professionals. Our comprehensive toolkits include best practices, templates, and resources to enhance patient care and streamline practice management. Whether you are looking for treatment protocols, patient education materials, or operational guides, our curated resources are here to support you in delivering exceptional oncology care.

ASSESSMENT FOR MAINTENANCE THERAPY IN OVARIAN CANCER

Provides a step-by-step guide for identifying appropriate candidates for maintenance therapy in ovarian cancer though your EMR.

CINV ASSESSMENT

Aids in the discussion of chemotherapy-induced nausea and vomiting with your patients.

DAROLUTAMIDE EMR ASSESSMENT TOOL

Provides a step-by-step guide for identifying appropriate candidates for darolutamide in non-metastatic castration-resistant prostate cancer through your EMR.

ILD PNEUMONITIS ASSESSMENT

Facilitates detection of interstitial lung disease (ILD) and pneumonitis through an interactive tool you can use with your patients.

IMMUNE-RELATED ADVERSE EVENT (irAE) MANAGEMENT TOOL

Aids in the management of immune-mediated adverse events through an interactive tool you can use with your patients.

LUSPATERCEPT EMR ASSESSMENT TOOL

Specialized guides for the OncoEMR and EPIC EMR platforms designed to facilitate the identification of eligible myelodysplastic syndrome (MDS) patients for luspatercept therapy.

RISK ASSESSMENT TOOL FOR TUMOR LYSIS SYNDROME

Assesses the risk of TLS in adult and pediatric patients to determine if rasburicase treatment should be initiated.

SOCIAL DETERMINANTS OF HEALTH TOOL

Aids in facilitating detection of social needs in patients and provides recommendations/resources to address those needs with the patient.

TUCATINIB PATIENT GUIDED RESOURCE

Downloadable resource available for clinician and patient use when utilizing tucatinib.

VENETOCLAX TLS RISK ASSESSMENT TOOL

Assists in determining TLS risk and initial dose reductions in patients starting on venetoclax therapy.

DOSE MODIFICATION CHARTS FOR VENETOCLAX TREATMENT

Assists in dose modifications that may be required when treating patients on venetoclax.

For access to all of our Resources, click to sign in here →

MEMBER RESOURCE TOOLKIT SPONSORED BY:

RESOURCES

Cost Avoidance Waste Tracker

Positive Quality Interventions

PQI in Action

OCE Sheets

IVE Sheets

Treatment Support Kits

PQI Podcast

Members

Member Resources

OPTA

Committees

Member Login

Events

Webinars

Spring Forum

Oncology Institute

PSO Annual Meeting

Fall Summit

contact@ncoda.org

315-655-4640

P.O. Box 468
Cazenovia, NY 13035

NCODA Logo

NCODA is a 501(c)(3) Organization